US prosecutors move to block DeFi Education Fund brief
US prosecutors are urging a federal judge to reject a DeFi Education Fund brief as the court considers a possible retrial in an Ethereum exploit case.
Every story in this section, newest first — page 353 of 373.
US prosecutors are urging a federal judge to reject a DeFi Education Fund brief as the court considers a possible retrial in an Ethereum exploit case.
FINRA has fined American Portfolios and ordered millions in restitution after finding undisclosed interest retention and misleading fee disclosures in its cash sweep programme.
Abu Dhabi is drawing global crypto firms with clear regulation, tax incentives, and strong institutional backing through its ADGM licensing framework.
QED Investors expects AI-driven credit models, execution-focused growth, and valuation discipline to shape the global fintech sector in 2026.
Nvidia (NASDAQ:NVDA) is reportedly in advanced discussions to acquire AI21 Labs, an Israel-based artificial intelligence startup, in a deal potentially valued at up to $3 billion, according to a report from Calcalist.
FTAI Aviation (NASDAQ:FTAI) saw its shares rise by 8.8% in the morning session after announcing the launch of FTAI Power, a new venture aimed at repurposing its CFM56 aircraft engines into 25-megawatt power turbines.
Nukkleus (NASDAQ:NUKK) has successfully closed its acquisition of Tiltan Software Engineering, making the Israeli defense technology firm a wholly owned subsidiary.
Lexaria Bioscience Corp. (NASDAQ:LEXX) announced positive findings from its Phase 1b clinical study GLP-1-H24-4, a 12-week chronic trial focusing on its DehydraTECH™ (DHT) delivery platform in comparison to the Rybelsus® control arm.
Binance has confirmed the suspension of Visa and Mastercard withdrawals for users in Ukraine following changes linked to its fiat payment provider.
Cycurion closed 2025 with a strong financial position, reporting an $80 million contracted backlog and bolstered liquidity as the company accelerates into 2026.
For the third quarter of 2025, Cycurion, which trades on the Nasdaq under the ticker CYCU, reported revenue of $3.83 million, a 13.9% year-over-year decrease. However, total assets grew to $32.31 million, an increase of 26.4%, and cash reserves rose significantly to $3.65 million, compared to just $0.04 million at the end of 2024.
The company saw net financing inflows of $10.78 million and is forecasting a Q1 2026 run-rate revenue of approximately $4.17 million, which would annualize to around $16.66 million.
Recent business wins include a multi-year telecom deployment with potential revenue exceeding $1 million, a state and local government data modernization project, and a $1.1 million county contract. Cycurion also declared a pro-rata share dividend of $0.0080 per share, payable around December 30, 2025.
Cycurion’s strategic focus on government and commercial sectors continues to drive growth as the company strengthens its foundation for expansion into 2026.
Denali Therapeutics (NASDAQ:DNLI) announced promising Phase 1/2 results for tividenofusp alfa (DNL310) in the treatment of Hunter syndrome, with the data published in The New England Journal of Medicine supporting an FDA Priority Review. The FDA has set a Prescription Drug User Fee Act (PDUFA) date for April 5, 2026.
VivoPower (NASDAQ:VVPR) announced it has entered into an exclusive heads of agreement to acquire a fully operational, >40MW data center facility in Norway, powered by 100% renewable hydropower.
Onchain perpetual contracts have surged to $972 billion in trading volume over the past 30 days, even as broader crypto market sentiment remains cautious.
Cvent, a global leader in meetings and hospitality technology, has entered into a definitive agreement to acquire ON24 (NYSE:ONTF) for approximately $400 million in an all-cash transaction.
Silo Pharma (NASDAQ:SILO) announced a non-binding Letter of Intent (LOI) with Allucent (US) LLC to support the Phase 1 clinical development of SPC-15, a nasal spray formulation under investigation.
Etoiles Capital Group (NASDAQ:EFTY) reported strong financial performance for the six months ended June 30, 2025, with a substantial 196.6% increase in revenue, reaching $1,800,576.
XOMA Royalty (NASDAQ:XOMA) announced the amendment of its 2006 collaboration agreement with Takeda (NYSE:TAK), marking a strategic shift in the economics of their partnership.
The deal, announced on Dec. 30, 2025, will see Takeda regain the majority of XOMA Royalty's economics related to mezagitamab, a monoclonal antibody for inflammatory diseases.
IM Cannabis Corp. (NASDAQ:IMCC) announced on Tuesday that it has launched a comprehensive review of strategic options to enter the United States cannabis market.
The pivot follows a landmark executive order signed by President Donald Trump on Dec. 18, 2025, which directs the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
InflaRx N.V. (NASDAQ:IFRX) provided an update on its Phase 3 study of vilobelimab in pyoderma gangrenosum (PG), outlining multiple data analyses after the trial was terminated earlier this year due to futility, following a recommendation from an Independent Data Monitoring Committee (IDMC).
ZenaTech (NASDAQ:ZENA) finalized three strategic acquisitions on Tuesday, marking its inaugural entry into the Canadian market and bringing its total deal count for 2025 to a staggering 19 companies.
Evogene (NASDAQ:EVGN), a leader in computational chemistry and generative AI for life sciences, announced the appointment of Dr. Olga Nissan as Vice President of Business Development, effective Jan. 1, 2026.
REE Automotive (NASDAQ:REE) reported financial results for the six months ended June 30, 2025, highlighting a strategic shift toward a technology-first and OEM-collaboration model as the company continues to develop its electric vehicle platform.
EUDA Health Holdings (NASDAQ:EUDA) has unveiled a nationwide stem cell extraction, cryostorage, and clinical delivery platform in China, marking a massive expansion of its footprint in the regional longevity and regenerative medicine sector.
Bridger Aerospace Group Holdings (NASDAQ:BAER) has finalized the acquisition of six additional aircraft, a strategic expansion that solidifies its position as the owner of the world’s largest private "Super Scooper" fleet ahead of the 2026 wildfire season.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy